# Major Review Finds Very Little Evidence for Cannabis Treating Anxiety, PTSD, or Psychotic Disorders > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-efficacy-anxiety-ptsd-review/ > **Published:** 2026-03-29T11:03:49-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:57:17-04:00 > **Clinical Summary:** A major cannabis efficacy anxiety PTSD review finds very little evidence supporting cannabis for these mental health conditions. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Mental HealthPtsdEvidence ReviewAnxiety[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) Why This Matters This review challenges widespread clinical assumptions about cannabis efficacy for psychiatric conditions, potentially affecting treatment decisions for thousands of patients currently using cannabis for anxiety and PTSD. The finding demands more rigorous evaluation of risk-benefit ratios in psychiatric cannabis prescribing. Clinical Summary A major systematic review found insufficient high-quality evidence supporting cannabis use for anxiety, PTSD, or psychotic disorders. The review likely examined randomized controlled trials and found gaps between patient usage patterns and demonstrable clinical efficacy. This aligns with broader challenges in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/), where patient reports of benefit often exceed what controlled studies can definitively establish. The finding is particularly significant given cannabis’s widespread off-label use for these conditions. Dr. Caplan’s Take “I see this daily in practice — patients reporting subjective benefit from cannabis for anxiety while our evidence base remains frustratingly thin. This review reinforces why we need honest conversations about what we know versus what we hope cannabis can do.” Clinical Perspective 🧠 Clinicians should continue individualizing treatment decisions while acknowledging evidence limitations to patients. This doesn’t invalidate patient experiences, but it should inform consent discussions about unproven benefits versus established risks. Consider validated psychiatric treatments as first-line options while [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) catches up to clinical demand. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Major%20review%20finds%20%E2%80%9Cvery%20little%20evidence%E2%80%9D%20for%20cannabis%20treating%20anxiety%2C%20PTSD%2C%20o...%20%40drcaplan&url=https%3A//www.instagram.com/p/DWdtapXAALs/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.instagram.com/p/DWdtapXAALs/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Major%20review%20finds%20%E2%80%9Cvery%20little%20evidence%E2%80%9D%20for%20cannabis%20treating%20anxiety%2C%20PTSD%2C%20o...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.instagram.com/p/DWdtapXAALs/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.instagram.com/p/DWdtapXAALs/](https://www.instagram.com/p/DWdtapXAALs/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What mental health conditions does this research focus on?](#What_mental_health_conditions_does_this_research_focus_on) - [What type of study methodology was used?](#What_type_of_study_methodology_was_used) - [Why is this research considered clinically relevant now?](#Why_is_this_research_considered_clinically_relevant_now) - [How might this research impact clinical practice?](#How_might_this_research_impact_clinical_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This study has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments that healthcare providers should monitor closely. #### What mental health conditions does this research focus on? The research examines cannabis use for mental health conditions, specifically PTSD and [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). These are among the most commonly cited reasons for medical cannabis use in clinical practice. #### What type of study methodology was used? This appears to be an evidence review, which systematically examines existing research on cannabis for mental health conditions. Evidence reviews help synthesize findings from multiple studies to provide clearer clinical guidance. #### Why is this research considered clinically relevant now? The study addresses emerging findings and policy developments in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) that warrant close monitoring. As cannabis laws evolve, healthcare providers need updated evidence to guide patient care decisions. #### How might this research impact clinical practice? This evidence review could help inform treatment protocols for PTSD and [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) involving cannabis. The findings may influence prescribing practices and patient counseling in jurisdictions where medical cannabis is legal. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Major review finds \u201cvery little evidence\u201d for cannabis treating anxiety, PTSD, or psychotic …”, “url”: “https://www.instagram.com/p/DWdtapXAALs/”, “datePublished”: “2026-03-29T11:21:49Z”, “about”: “major review finds very little evidence”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [A Lancet Psychiatry study found no evidence cannabinoids treat anxiety, PTSD. In NY, any …](https://cedclinic.com/cannabinoid-efficacy-anxiety-ptsd-lancet-study/) This article discusses a Lancet Psychiatry study that found no evidence supporting cannabinoids for anxiety and [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/). [Read More](https://cedclinic.com/cannabinoid-efficacy-anxiety-ptsd-lancet-study/) [Huge study finds no evidence cannabis helps anxiety, depression, or PTSD | Catherine Adenle](https://cedclinic.com/cannabis-efficacy-mental-health-conditions-study/) A large-scale study examining cannabis effects on anxiety, depression, and PTSD found no supporting evidence for efficacy. [Explore Study](https://cedclinic.com/cannabis-efficacy-mental-health-conditions-study/) [Is Cannabis Effective for Treating Mental Health Disorders? – Labroots](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) An in-depth review exploring the effectiveness of cannabis in treating various mental health disorders. [Learn More](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).